The Cardiovascular Implants Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Cardiovascular Implants Market:
https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report
According to The Business Research Company’s Cardiovascular Implants Global Market Report 2024, The cardiovascular implants market size has grown strongly in recent years. It will grow from $24.81 billion in 2023 to $26.8 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to aging population and cardiovascular risk, lifestyle-related cardiovascular risk factors, improvements in diagnostic technologies, growing awareness and screening programs, government initiatives for cardiovascular health..
The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $34.59 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to personalized medicine approaches, focus on minimally invasive procedures, global collaboration in cardiovascular research, healthcare policy emphasis on preventive interventions, patient-centric cardiovascular care.. Major trends in the forecast period include advancements in drug-eluting stents, rise of next-generation heart valves, increasing integration of artificial intelligence (ai), focus on minimally invasive implantation techniques, personalized and patient-specific implants, development of leadless pacemakers..
The rising prevalence of heart disorders is expected to propel the growth of the cardiovascular implants market going forward. Heart disorders refer to various medical conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and valve disorders. The prevalence of heart diseases, such as coronary artery disease and heart failure, drives the demand for cardiovascular implants, including stents and pacemakers, to treat these conditions. These implants support the heart and circulation in patients with heart failure, help the heart beat in a regular rhythm, and keep track of the heart rhythm. For instance, in April 2023, according to the British Heart Foundation, a UK-based cardiovascular research charity, the overall number of deaths in Scotland from all heart and circulatory illnesses was 17,639 in 2021, up from 17,448 in 2020. In addition, the number of deaths from coronary heart disease in the UK in 2021 will be 65,579, up from 64,170 in 2020. Therefore, the rising prevalence of heart disorders is driving the growth of the cardiovascular implants market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13399&type=smp
The cardiovascular implants market covered in this report is segmented –
1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
2) By Material: Metals and Alloys, Polymers, Biological Materials
3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers
Major companies operating in the cardiovascular implants market are increasing their focus on adopting advanced technology with artificial intelligence (AI) to maximize their profits in the market and enhance patient care and treatment precision. The advancement of cardiac monitoring technology refers to continuously tracking and recording a patient’s heart activity to diagnose and manage heart conditions. For instance, in June 2023, BIOTRONIK SE & Co. KG, a Germany-based medical technology company, launched the first global implantation of its BIOMONITOR IV implantable cardiac monitor (ICM). BIOMONITOR IV is a cutting-edge ICM that combines BIOTRONIK’s SmartECG technology with artificial intelligence to cut false-positive detections by 86% while retaining 98% of real episodes. In addition to the sophisticated artificial intelligence, there are several other advantages for patients and healthcare professionals who use BIOMONITOR IV. Lengthy battery life and wireless connectivity provide smooth data transmission and remote monitoring, decreasing the need for frequent in-person clinic visits.
The cardiovascular implants market report table of contents includes:
1. Executive Summary
2. Cardiovascular ImplantsMarket Characteristics
3.Cardiovascular Implants Market Trends And Strategies
4.Cardiovascular Implants Market analysis
5.Cardiovascular Implants Market Size And Growth
6.Cardiovascular Implants Segmentation
7.Cardiovascular Implants Regional And Country Analysis
.
.
.
27.Cardiovascular Implants Competitive Landscape And Company Profiles
28.Cardiovascular Implants Key Mergers And Acquisitions
29.Cardiovascular Implants Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- B. Braun Melsungen AG
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
